Century Therapeutics, a University City biotech that wants to use adult stem cells to create cell therapies to fight cancer and autoimmune disease, said in two regulatory filings this week that it is ...

Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar ...

For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.

Health-care companies rose as traders jumped back into the riskiest niches of the stock market, including biotech.

Longevity Health Holdings to remain listed on Nasdaq South Side biotech company announces merger plans South Side biotech ...

On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...

Charles E. Hamner Jr., a highly respected and accomplished scientist, university administrator and pharmaceutical executive who led the North Carolina Biotechnology Center during its formative years, ...

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

Local is defined as St. Louis, St. Charles, Lincoln, Warren, Franklin, Washington and Jefferson counties and the city of St. Louis in Missouri; and St. Clair, Madison, Jersey, Clinton, Calhoun, ...

Ocugen co-founder and CEO Shankar Musunuri, Ph.D. explains what biotech leaders can learn from the Philadelphia Eagles, an agile team with a championship mindset.